Connors Investor Services’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Connors Investor Services’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,064	Closed	-$215K	–	153
2020 Q3	$215K	Hold	4,064	–	–	0.03%	120
2020 Q2	$249K	Hold	4,064	–	–	0.04%	116
2020 Q1	$230K	Sell	4,064 -531	-12%	-$30.3K	0.04%	109
2019 Q4	$262K	Buy	+4,595	New	+$244K	0.03%	124

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Connors Investor Services's BSTC Position: Q4 2020 in Review

Connors Investor Services sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 4,064 shares — an estimated $215K sold.

Connors Investor Services first reported a position in BSTC in Q4 2019 and held it in 4 quarters. The position peaked at $262K in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Connors Investor Services reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Connors Investor Services sold 4,064 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $215K.
Connors Investor Services first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 4 quarters.
Connors Investor Services's BioSpecifics Technologies Corp. position peaked at $262K in Q4 2019.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Connors Investor Services's 13F filing for Q4 2020, filed 16 Feb 2021.